Pneumococcal disease: Emergence of serotypes 19A and 7F following conjugate pneumococcal vaccination in a Mexican hospital

Journal of Infection in Developing Countries

Volumn 6, Issue 6, 2012, Pages 516-520

  Chacon Cruz, Enrique ^a   Velazco Mendez, Yazbeck ^a   Navarro Alvarez, Samuel ^a   Rivas Landeros, Rosa M ^a   Volker, Maria Luisa ^a   Lopez Espinoza, Graciano ^a  

^a General Hospital of Tijuana   (Mexico)

Author keywords

Mexico; Pneumococcal conjugate vaccines; Pneumococcal invasive disease; Serotypes 19A and 7F; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MASTOIDITIS; MEXICO; NEISSERIA MENINGITIDIS; PLEURA EMPYEMA; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84862674297     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1954     Document Type: Article

References (17)

1. Overturf GD with the American Academy of Pediatrics Committee on Infectious Diseases (2000) Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and pollysacharide vaccines and antibiotic prophylaxis. Pediatrics 106: 367-376.
2. Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B (2004) Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern Califoria Kaiser Permanente. Ped Infect Dis J 23: 485-489.
3. Center KJ (2007) Prevenar vaccination: review of the global data. 2006. Vaccine 20: 3085-3089.
4. Gomez-Barreto D, Espinosa-Monteros LE, Lopez-Enriquez C, Jiménez-Rojas V, Rodríguez-Suárez R (2010) Invasive pneumococcal disease in a third level pediatric hospital in Mexico City: epidemiology and mortality risk factors. Salud Publica Mex 52: 391-397.
5. Villasenor-Sierra A, Lomas-Bautista M, Aguilar-Benavides S, Martinez-Aguilar G (2008) Serotypes and susceptibility of Streptococcus pneumoniae strains isolated from children in Mexico. Salud Publica Mex 50: 330-333.
6. Espinosa-de Los Monteros LE, Jimenez-Rojas V, Aguilar-Ituarte F, Cashat-Cruz M, Reyes-López A, Rodríguez-Suárez R, Kuri-Morales P, Tapia-Conyer R, Gómez-Barreto D.(2007) Streptococcus pneumoniae isolates in healthy children attending day-care centers in 12 states of Mexico. Salud Publica Mex 49: 249-255. 7.
7. http://new.paho.org/hq/dmdocuments/2009/SirevaII2007.pdf:195-7. Accessed January 2011.
8. Isaacman DJ, McIntosh ED, Reinert RR (2010) Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 14: e197-e209.
9. Linares J, Ardanuy C, Pallares R, Fenoll A (2010) Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30 year period. Clin Microbiol Infect 16: 402-410.
10. Tan TQ (2010) Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USA. Expert Rev Anti Infect Ther 8: 117-125.
11. Lynch JP 3rd, Zhanel GG (2010) Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 16: 217-225.
12. Arredondo-Garcia JL, Calderon E, Echániz-Aviles G, Soto-Noguerón A, Arzate P, Amabile-Cuevas CF. (2011) Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolates causative of invasive diseases in Mexican children. J Infect Dev Ctries 5: 119-122.
13. Dagan R (2009) Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Infect Suppl 3: 21-23.
14. Reinert R, Jacobs MR, Kaplan SL (2010) Pneumococcal disease caused by serotype 19A: review of the literatura and implications for future vaccine development. Vaccine 11: 4249-4259.
15. Hausdorff WP, Hoet B, Schuerman L (2010) Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A? BMC Pediatr 10: 4.
16. Van Gills EJ, Veenhoven RH, Hak E, Rodenburg GD, Keijzers WC, Bogaert D, Trzcinski K, Bruin JP, van AlphenL, vanderEnde A, SandersEA.(2010) Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. JAMA 304: 1099-1106.
17. http://www.investinbaja.gob.mx/flaboral/poblacion.htm Accessed January2011.